Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
112
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Rengui Zhou1 Department of Hematology and Oncology, The 904 Hospital of the PLA (Chinese People’s Liberation Army), Wuxi, People’s Republic of China
,
Lei Song1 Department of Hematology and Oncology, The 904 Hospital of the PLA (Chinese People’s Liberation Army), Wuxi, People’s Republic of China
,
Wenwen Zhang1 Department of Hematology and Oncology, The 904 Hospital of the PLA (Chinese People’s Liberation Army), Wuxi, People’s Republic of China
,
Lin Shao2 Burning Rock Biotech, Guangzhou, Guangdong, People’s Republic of China
,
Xi Li2 Burning Rock Biotech, Guangzhou, Guangdong, People’s Republic of China
&
Xiangyong Li1 Department of Hematology and Oncology, The 904 Hospital of the PLA (Chinese People’s Liberation Army), Wuxi, People’s Republic of ChinaCorrespondence[email protected]
Pages 2847-2851 | Published online: 28 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.